According to Zentalis Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -A$0.3 B. In 2023 the company made an earning of -A$0.42 B a decrease over its 2022 earnings that were of -A$0.34 B.The earnings displayed on this page is the company's Pretax Income.